CN103230449A - Rupikang traditional Chinese medicine - Google Patents
Rupikang traditional Chinese medicine Download PDFInfo
- Publication number
- CN103230449A CN103230449A CN2013101125832A CN201310112583A CN103230449A CN 103230449 A CN103230449 A CN 103230449A CN 2013101125832 A CN2013101125832 A CN 2013101125832A CN 201310112583 A CN201310112583 A CN 201310112583A CN 103230449 A CN103230449 A CN 103230449A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- nodules
- breast
- milligram
- milligrams
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Rupikang traditional Chinese medicine, which comprises 20-30mg of Salvia miltiorrhiza, 20-30mg of motherwort, 5-10mg of Scutellaria barbata and 5-10mg of pueraria. The prepared Rupikang traditional Chinese medicine has the characteristics of promoting qi circulation to activate blood, eliminating stagnation and removing swelling, dispersing stasis and dredging collaterals, improving microcirculation, softening hardness to dissipate stagnation, and promoting blood circulation to remove blood stasis.
Description
Technical field
The present invention relates to a kind of nodules of the breast health Chinese medicine.
Background technology
For a long time, the Chinese medicine preparation of China is produced and is commonly had that technology is simple and crude, kind is single, the backward situation of difficult quality guarantee, become the serious hindrance that Chinese medicine goes to the world, therefore, in order to revitalize Chinese medicine, give full play to the advantage of Chinese medicine compound, integrate with international most advanced level, improve the international competitiveness of tcm product, Chinese medicine industry, adopt modern science and technology research compound Chinese medicinal preparation, it is very necessary and very urgent formulating novel modern Chinese medicine.
The BUPIXIAO PIAN of Xiao Shouing derives from old docter of TCM's proved recipe in the market, is the Chinese patent medicine of the treatment cyclomastopathy formed of ten five tastes medical materials, now records in one one of Chinese Pharmacopoeia version in 2005, has the software eliminating stagnation, an effect of pain, heat-clearing and toxic substances removing of disappearing of invigorating blood circulation.The BUPIXIAO PIAN curative effect is clear and definite, toxic and side effects is low.But, since historical reasons, the BUPIXIAO PIAN of development and production in 1984, its extracting method, preparation process, research level such as quality standard, pharmacological effect lags far behind the medical standards and norms of the present current international practice, and the RUPIXIAO extract is big, and is thick, black, quality stability is poor.At present known BUPIXIAO PIAN dosage form is single, with low content of technology, and tablet treatment symptom is single, can't satisfy domestic and international main flow market to modern Chinese medicine product technology and requirement.
Summary of the invention
The object of the present invention is to provide and have promoting flow of QI and blood, mass dissipating and swelling eliminating, dredge a kind of nodules of the breast health Chinese medicine of characteristics such as blood stasis and smoothing collaterals, microcirculation improvement, hard masses softening and resolving, blood circulation promoting and blood stasis dispelling.
Technical scheme of the present invention is: a kind of nodules of the breast health Chinese medicine, comprise Herba Linderniae Crustaceae, Agrimony, Herba Scutellariae Barbatae, Radix Puerariae, and each composition consumption proportion is Herba Linderniae Crustaceae 20-30 milligram, Agrimony 20-30 milligram, Herba Scutellariae Barbatae 10-20 milligram, Radix Puerariae 10-20 milligram.
In a preferred embodiment of the present invention, described each composition consumption proportion of nodules of the breast health Chinese medicine is 30 milligrams of Radix Salviae Miltiorrhizaes, 30 milligrams of Herba Leonuris, 10 milligrams of Herba Scutellariae Barbataes, 10 milligrams of Radix Puerariaes.
In a preferred embodiment of the present invention, described nodules of the breast health Chinese medicine is capsule, powder or decoction.
A kind of nodules of the breast health Chinese medicine of the present invention has promoting flow of QI and blood, mass dissipating and swelling eliminating, dredges characteristics such as blood stasis and smoothing collaterals, microcirculation improvement, hard masses softening and resolving, blood circulation promoting and blood stasis dispelling.
The specific embodiment
Below in conjunction with preferred embodiment of the present invention is described in detail, thereby so that advantages and features of the invention can be easier to be it will be appreciated by those skilled in the art that protection scope of the present invention is made more explicit defining.
In one embodiment, a kind of nodules of the breast health Chinese medicine comprises Herba Linderniae Crustaceae, Agrimony, Herba Scutellariae Barbatae, Radix Puerariae, and each composition consumption proportion is Herba Linderniae Crustaceae 20-30 milligram, Agrimony 20-30 milligram, Herba Scutellariae Barbatae 10-20 milligram, Radix Puerariae 10-20 milligram.
Further specify, described each composition consumption proportion of nodules of the breast health Chinese medicine is 30 milligrams of Radix Salviae Miltiorrhizaes, 30 milligrams of Herba Leonuris, 10 milligrams of Herba Scutellariae Barbataes, 10 milligrams of Radix Puerariaes.
Further specify, described nodules of the breast health Chinese medicine is capsule, powder or decoction.
The medication effect observation of the common nodules of the breast disease of one embodiment:
(1) acute mastitis
Women: age 18-40 one full year of life, breast-feeding female, 50 examples
Symptom: big multiple-case breast redness, scorching hot, hot 35 examples of the red and swollen candle of left side pain, the right side is 15 examples then.
Usage and dosage: oral, each two, every day three times.
Effect: after taking medicine 3 days, scorching hot disappearance 43 examples of congestion and swelling pain, whole 45 examples that disappear of symptom after taking medicine 7 days, 5 examples are imitated and are shown.Effective percentage 100%.
(2), cyclomastopathy, enclosed mass, abdominal mass addiction
Women: age 25-45 one full year of life, 50 examples
Symptom:
1, pain.Normal is distending pain or twinge, can involve the one or both sides breast, sees that so that a lateral deviation is heavy the pain severe patient can not be touched more, even influences daily life and work.Pain also can be to Ipsilateral axillary fossa, the breast side of body or the radiation of shoulder back based on the lump in breast place, and some then shows as sore nipples or itches.Mastalgia often before menstruation a couple of days occur or increase the weight of, the back pain of passing through obviously alleviates or disappears, pain also can fluctuate with emotion changes.This pain relevant with menstrual cycle and emotion changes is the main feature of cyclomastopathy clinical manifestation.2, lump in breast.Lump can be sent out in one-sided or bilateral breast, and is single or multiple, and good sending out gone up quadrant outside breast, also be found in other quadrants.The lump shape has sheet bulk, nodositas, streak, graininess etc., wherein block for seeing with sheet more.The lump border is not obvious, and quality is medium or tough slightly firmly, and is movable good, do not have adhesion with surrounding tissue, and tenderness is often arranged.Lump is not of uniform size, and is big as little person such as the foxtail millet grain, and big person can exceed 3～4cm.Lump in breast also has the characteristics that change with menstrual cycle, and lump increases hardening before the menstruation, and lump dwindles deliquescing behind the menstrual onset.3, nipple discharge.Nipple discharge can appear in small number of patients, are spontaneous discharge, olive drab(O or brown serosity discharge.4, menoxenia.This patient can doublely see before and after the menstruation irregularly, amount less or color light, can accompany dysmenorrhea.5, feelings will changes.The normal emotion will of patient smooth or susceptible to lose temper due to restlessness, anger, psychentonia or tired postemphasis whenever.
Usage and dosage: oral, each two, every day three times.
Effect: after taking medicine 7 days, distending pain or twinge 35 examples that disappear, 41 examples are dwindled in the deliquescing of lump symptom after taking medicine 15 days, 38 examples that all disappear 50 day after tomorrow of taking medicine, 5 routine produce effects, 3 examples effectively, 1 example is invalid.Effective percentage 98%.
The medication effect observation of another embodiment female reproduction tumor:
Women: age 10-60 one full year of life.10 examples
(1) symptom of ovarian tumor
1, the acute abdomen ovarian tumor is cystic teratoma or simple ovarian cyst, and these tumors mostly are one-sided, and the base of a fruit is very long, easily reverses.Because reversing bloodstream blocking, cause ischemia and capsule internal hemorrhage, produce serious pain.
2, chronic abdominal discomfort, this is the modal symptom of ovarian tumor.
3, unusual vaginal hemorrhage, this mainly is the symptom that functional ovarian tumor produces.Ovarian tumor transfers to the uterus or vagina also can cause unusual vaginal hemorrhage.
(2) symptom of cervical cancer
1, vaginal hemorrhage, irregular vagina bleeding, especially contact bleeding (be behind the sexual life or hemorrhage after the gynecologial examination) and vaginal hemorrhage after menopause are cervical cancer patient's cardinal symptoms.Cauliflower form cervical cancer bleeding is morning, and amount of bleeding is more.
2, vaginal secretions increases, and white is thin, and water sample, water from washing rice sample or courage and uprightness have stench flavor.When the cancerous tissue ulceration infected, secretions can be purulence, companion's stench.
3, performance in late period owing to infiltration, the transfer of cancerous protuberance, the symptom of corresponding site and even whole body can occur.As frequent micturition, urgent micturition, rectal tenesmus, constipated, lower limb swell and ache, sciatica, hydronephrosis, and renal failure, uremia etc. finally cause whole body depletion.
Usage and dosage: oral, each two, every day three times.
Effect: first course for the treatment of, occurring the toxin expelling phenomenon behind the couple of days has secretions to discharge, and spirit and other symptom can obviously be improved, and stool can satisfy gradually normal after 7-15 days.Second and third course for the treatment of, the tumor degree is disappearing of early metaphase or dwindles after 30 days.The person controlled tumor growth or progressively dwindled late period, the quality of making the life better, and the existence of band tumor prolongs life, extenuates symptom.Medicine across-the-board regulation fuselage state, toxin expelling rushes down poison, along with healthy energy in the body reach a certain height, begin the DNA gene of cancerous cell is produced inhibition, simultaneously immunologic function strengthens, and patient's improvements that can progressively feel relief at this moment locks human righteousness's further raising, cancerous cell to each period suppresses (a growth of cancer cells cycle was generally about 60-120 days) comprehensively, and cancerous cell progressively thoroughly perishes of oneself.Pain among cancer patients alleviated in 5 days, and cancer patient's appetite increased in 10 days, and spirit is improved, and 30 days cancerous protuberance pieces stop to increase, weight increase, and S-CEA descended in 60 days, and the cancerous protuberance piece dwindles, and red leukocyte increases.7 routine produce effects, 2 examples are effective, and 1 example is invalid.Effective percentage 90%.The invention provides a kind of nodules of the breast health Chinese medicine, have promoting flow of QI and blood, mass dissipating and swelling eliminating, dredge characteristics such as blood stasis and smoothing collaterals, microcirculation improvement, hard masses softening and resolving, blood circulation promoting and blood stasis dispelling.
The specific embodiment of the present invention; but protection scope of the present invention is not limited thereto; any those of ordinary skill in the art are in the disclosed technical scope of the present invention, and variation or the replacement that can expect without creative work all should be encompassed within protection scope of the present invention.Therefore, protection scope of the present invention should be as the criterion with the protection domain that claims were limited.
Claims (3)
1. nodules of the breast health Chinese medicine, it is characterized in that: comprise Radix Salviae Miltiorrhizae, Herba Leonuri, Herba Scutellariae Barbatae and Radix Puerariae, each composition consumption proportion is Radix Salviae Miltiorrhizae 20-30 milligram, Herba Leonuri 20-30 milligram, Herba Scutellariae Barbatae 5-10 milligram, Radix Puerariae 5-10 milligram.
2. nodules of the breast health Chinese medicine according to claim 1, it is characterized in that: described each composition consumption proportion of nodules of the breast health Chinese medicine is 30 milligrams of Radix Salviae Miltiorrhizaes, 30 milligrams of Herba Leonuris, 10 milligrams of Herba Scutellariae Barbataes, 10 milligrams of Radix Puerariaes.
3. nodules of the breast health Chinese medicine according to claim 1, it is characterized in that: described nodules of the breast health Chinese medicine is capsule, powder or decoction.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013101125832A CN103230449A (en) | 2013-04-02 | 2013-04-02 | Rupikang traditional Chinese medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013101125832A CN103230449A (en) | 2013-04-02 | 2013-04-02 | Rupikang traditional Chinese medicine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103230449A true CN103230449A (en) | 2013-08-07 |
Family
ID=48878565
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2013101125832A Pending CN103230449A (en) | 2013-04-02 | 2013-04-02 | Rupikang traditional Chinese medicine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103230449A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109481560A (en) * | 2018-12-19 | 2019-03-19 | 吴巧维 | A kind of formula inhibiting the diffusion of the cancer cell of cervical carcinoma and breast cancer |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5061491A (en) * | 1988-12-30 | 1991-10-29 | Deryabin Alexandr M | Medicinal agent and method for treatment of mastitis in animals and humans |
| CN1321500A (en) * | 2001-04-23 | 2001-11-14 | *** | Method for preventing and curing diseases by using kakonein preparation |
| CN101167761A (en) * | 2006-10-29 | 2008-04-30 | 宜兴市鹏鹞天然保健营养素有限公司 | Application of glossy ganoderma wall damaged spore powder and glossy ganoderma spore oil in treating woman mastoproliferation |
| WO2009033103A1 (en) * | 2007-09-07 | 2009-03-12 | Bionovo, Inc. | Estrogenic extracts of pueraria lobata willd, ohwi of the leguminosae family and uses thereof |
| CN102697898A (en) * | 2012-01-04 | 2012-10-03 | 陈玉堂 | Medicament for regulating endocrine and curing dysmenorrheal, mammary gland hyperplasia and breast dysplasia |
| CN102716417A (en) * | 2012-06-15 | 2012-10-10 | 祁连明 | Traditional Chinese medicine preparation for treating gynaecopathia and preparation method of preparation |
| CN102772523A (en) * | 2012-08-09 | 2012-11-14 | 谢瑜 | Bitter glossy ganoderma composition for oncotherapy and preparation method of bitter glossy ganoderma composition |
-
2013
- 2013-04-02 CN CN2013101125832A patent/CN103230449A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5061491A (en) * | 1988-12-30 | 1991-10-29 | Deryabin Alexandr M | Medicinal agent and method for treatment of mastitis in animals and humans |
| CN1321500A (en) * | 2001-04-23 | 2001-11-14 | *** | Method for preventing and curing diseases by using kakonein preparation |
| CN101167761A (en) * | 2006-10-29 | 2008-04-30 | 宜兴市鹏鹞天然保健营养素有限公司 | Application of glossy ganoderma wall damaged spore powder and glossy ganoderma spore oil in treating woman mastoproliferation |
| WO2009033103A1 (en) * | 2007-09-07 | 2009-03-12 | Bionovo, Inc. | Estrogenic extracts of pueraria lobata willd, ohwi of the leguminosae family and uses thereof |
| CN102697898A (en) * | 2012-01-04 | 2012-10-03 | 陈玉堂 | Medicament for regulating endocrine and curing dysmenorrheal, mammary gland hyperplasia and breast dysplasia |
| CN102716417A (en) * | 2012-06-15 | 2012-10-10 | 祁连明 | Traditional Chinese medicine preparation for treating gynaecopathia and preparation method of preparation |
| CN102772523A (en) * | 2012-08-09 | 2012-11-14 | 谢瑜 | Bitter glossy ganoderma composition for oncotherapy and preparation method of bitter glossy ganoderma composition |
Non-Patent Citations (2)
| Title |
|---|
| 朱磊等: "乳核散冲剂质量控制研究", 《辽宁药物与临床》, vol. 7, no. 2, 31 December 2004 (2004-12-31), pages 90 - 91 * |
| 简阳市中瑜生物工程有限责任公司: "苦灵芝乳癖康胶囊药效观察", 《HTTP://HI.BAIDU.COM/KIRXJHNSMCBDQUD/ITEM/F3455A14A6A1A109B98A1AF6》, 21 May 2010 (2010-05-21), pages 1 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109481560A (en) * | 2018-12-19 | 2019-03-19 | 吴巧维 | A kind of formula inhibiting the diffusion of the cancer cell of cervical carcinoma and breast cancer |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102370725A (en) | Traditional Chinese medicine compound preparation for treating chronic pelvic inflammation and preparation method thereof | |
| CN102008651B (en) | Traditional Chinese medicine for treating and preventing tumors and production method thereof | |
| CN102716383B (en) | Traditional Chinese medicine composition for treating Crohn's disease | |
| CN103550719B (en) | A kind of Chinese medicine composition for the treatment of nasopharyngeal carcinoma | |
| CN103463494B (en) | One treats hypertensive Chinese medicine preparation | |
| CN103191392B (en) | Chinese medicinal preparation for treating gastric diseases | |
| CN101062146A (en) | Chinese traditional medicine for treating gastric cancer and bone cancer | |
| CN102688317A (en) | Traditional Chinese medicine for treating liver cancer | |
| CN103223101A (en) | Traditional Chinese medicine for treating thyroid cyst | |
| CN101085269B (en) | Internal-applied traditional Chinese medicine composition for treating lung cancer | |
| CN103230449A (en) | Rupikang traditional Chinese medicine | |
| CN105902751A (en) | Traditional Chinese medicine composition for treating cervical cancer | |
| CN101406522B (en) | Use of pharmaceutical composition in preparing medicament for treating viral influenza | |
| CN104027447B (en) | A kind of Chinese medicine of Therapeutic cancer | |
| CN103285172B (en) | Chinese medicament composition for treating myoma of uterus and endometrial cancer and application thereof | |
| CN105561035A (en) | Traditional Chinese medicine capsules for treating lung cancer and preparation method thereof | |
| CN102430054B (en) | Applications of traditional Chinese medicinal compound preparation for removing toxicity, resisting cancer, activating blood and dissipating mass | |
| CN105106846B (en) | Treat the formula of Chinese materia medica preparation of uterus adenomyosis | |
| CN103585358A (en) | Mastitis treatment anti-inflammation and swelling subsiding oral liquid and preparation method thereof | |
| CN103223046A (en) | Traditional Chinese medicine for treating hyperplasia of mammary glands | |
| CN102920977B (en) | Traditional Chinese medicine composition for treating liver cancer | |
| CN102579963B (en) | Traditional Chinese medicine for treating mastadenoma | |
| CN102671111B (en) | Chinese medicinal composition for treating malignant soft tissue neoplasm | |
| CN1899363A (en) | Chinese medicine composition for increasing immunity and its preparing method | |
| CN1256976C (en) | Anti-cancer Chinese medicinal composition and its preparing method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20130807 |